Aron Shapiro is listed as a director on 7 SEC Form D filings by 2 issuers between Mar 2010 and Apr 2026: KIORA PHARMACEUTICALS INC (Encinitas, CA — pharmaceuticals — 2021–2026; $15M reported sold to 32 investors) and Entopica Therapeutics, Inc. (Andover, MA — pharmaceuticals — 2010; $1M reported sold to 1 investors).
What this means 2 separate companies raised money with this person listed as director, over about 16 years. Across those companies the filings report $16M sold in total.
Listed alongside Brian Strem (6 shared filings), Praveen Tyle (6 shared filings), Kenneth Gayron (5 shared filings), David Hollander (4 shared filings), Eric Daniels (4 shared filings) and 10 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Aron. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 7 public filings for Aron Shapiro and found 4 differences, 1 worth asking the sponsor about: Form D filed 380 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.